What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Gene
Chloe L. Thio spends much of her time researching Immunology, Virology, Hepatitis B, Hepatitis B virus and Hepatitis C virus.
Her Immunology study combines topics from a wide range of disciplines, such as Internal medicine and Acquired immunodeficiency syndrome.
Specifically, her work in Virology is concerned with the study of Virus.
Chloe L. Thio has researched Hepatitis B in several fields, including Liver disease, Lamivudine and Viral load.
Her research investigates the connection between Hepatitis B virus and topics such as Viral hepatitis that intersect with issues in Orthohepadnavirus, Hepatocellular carcinoma, Liver cancer and Hepadnaviridae.
Chloe L. Thio mostly deals with Hepacivirus in her studies of Hepatitis C virus.
Her most cited work include:
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virus (1818 citations)
- HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection (1012 citations)
- HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) (841 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Immunology, Virology, Hepatitis B virus, Hepatitis B and Internal medicine.
Her studies examine the connections between Immunology and genetics, as well as such issues in Liver disease, with regards to Cirrhosis.
The Virology study combines topics in areas such as Genotype and Haplotype.
Her research integrates issues of Coinfection, Hepatocellular carcinoma and Transmission in her study of Hepatitis B virus.
Chloe L. Thio usually deals with Hepatitis B and limits it to topics linked to Lamivudine and Reverse-transcriptase inhibitor, Zidovudine and Drug resistance.
Her Internal medicine research incorporates elements of Gastroenterology, Multicenter AIDS Cohort Study and Oncology.
She most often published in these fields:
- Immunology (50.00%)
- Virology (46.77%)
- Hepatitis B virus (37.10%)
What were the highlights of her more recent work (between 2018-2021)?
- Internal medicine (30.65%)
- Hepatitis C virus (23.66%)
- Hepatitis B virus (37.10%)
In recent papers she was focusing on the following fields of study:
Chloe L. Thio mostly deals with Internal medicine, Hepatitis C virus, Hepatitis B virus, Coinfection and Virology.
The concepts of her Internal medicine study are interwoven with issues in Multicenter AIDS Cohort Study, Antiretroviral therapy and Oncology.
Her work carried out in the field of Hepatitis C virus brings together such families of science as SNP, Logistic regression, Hepatitis C, Allele and Genotype.
Chloe L. Thio is studying HBsAg, which is a component of Hepatitis B virus.
Her Virus and cccDNA study in the realm of Virology connects with subjects such as Laser capture microdissection.
Her biological study spans a wide range of topics, including Odds ratio, Genome-wide association study and Immunology.
Between 2018 and 2021, her most popular works were:
- CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome. (29 citations)
- Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016. (27 citations)
- Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus (12 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Acquired immunodeficiency syndrome
- Gene
Chloe L. Thio focuses on Hepatitis B virus, Coinfection, Immunology, Internal medicine and Liver disease.
A significant part of her Hepatitis B virus research incorporates Virology and Virus studies.
Her research in Virology intersects with topics in Hepatocellular carcinoma, Antibody and National Health and Nutrition Examination Survey.
The study incorporates disciplines such as Hepatitis B and Transcriptional regulation in addition to Virus.
Chloe L. Thio merges Immunology with CXCL10 in her study.
Her research investigates the connection with Liver disease and areas like Absolute risk reduction which intersect with concerns in Hepatitis C virus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
